Biotech RadarJobs updated

COMPANY

Tavanta Therapeutics

tavanta.com ↗

Clinical Phase 3

Profile checked Oct 10, 2026

Keywords: Metastatic Castration-resistant Prostate Cancer Metastatic Castration-sensitive Prostate Cancer Metastatic Prostate Cancer TAVT-45

1Trials (company is sponsor)

Timeline

  1. Trial start Phase 3: TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer source ↗

Clinical trials (lead sponsor) 1

RecordTitlePhaseStatusStartPrimary completion
NCT04887506TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate CancerPhase 3CompletedMay 5, 2021Oct 20, 2022 (actual)
Feedback